BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
The Beauty Health Company (SKIN) PT Raised to $3 at Piper Sandler
March 13, 2024 6:42 AM EDTPiper Sandler analyst Korinne Wolfmeyer raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $3.00 (from $2.00) while maintaining a Underweight rating.
The analyst comments "Both the device and operational issues SKIN is facing don't necessarily seem to be in the... More
The Beauty Health Company (SKIN) PT Raised to $4 at TD Cowen
March 13, 2024 6:07 AM EDTTD Cowen analyst Oliver Chen raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $4.00 (from $2.50) while maintaining a Market Perform rating.
The analyst comments "4Q23 EPS and FY24 guide were better than feared and with a 2H weighted... More
The Beauty Health Company (SKIN) PT Raised to $4 at Stifel
March 13, 2024 4:34 AM EDTStifel analyst Jonathan Block raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $4.00 (from $3.00) while maintaining a Hold rating.
The analyst comments "In our opinion, 4Q23 offered few surprises (recall, components of 4Q23 were already preannounced). Revenue of... More
The Beauty Health Company (SKIN) Reports In-Line Q4 EPS
March 12, 2024 4:15 PM EDTThe Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $96.8 million versus the consensus estimate of $87.22 million.
GUIDANCE:
The Beauty Health Company sees Q1 2024 revenue of $77-83... More
